Connection

RIMA M SALIBA to Fusion Proteins, bcr-abl

This is a "connection" page, showing publications RIMA M SALIBA has written about Fusion Proteins, bcr-abl.
Connection Strength

0.039
  1. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Bone Marrow Transplant. 2004 May; 33(10):1005-9.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.